The relation between catecholamines, glucagon and pancreatic polypeptide during hypoglycaemia in man

Area of Science:

• Endocrinology
• Neuroscience

Background:

• Insulin-induced hypoglycemia is a critical condition affecting glucose regulation.
• The role of catecholamines, particularly adrenaline, in counter-regulatory hormonal responses is well-established.

Purpose of the Study:

• To investigate the impact of insulin-induced hypoglycemia on plasma concentrations of catecholamines and pancreatic hormones.
• To determine if adrenaline is essential for the release of glucagon and pancreatic polypeptide (PP) during hypoglycemia in humans.

Main Methods:

• A comparative study involving 6 adrenalectomized subjects and 6 healthy controls.
• Administration of insulin (0.15 IU/kg) to induce hypoglycemia.
• Measurement of plasma concentrations of insulin, blood glucose, adrenaline, noradrenaline, dopamine, glucagon, and pancreatic polypeptide (PP).

Main Results:

• Insulin-induced hypoglycemia and subsequent blood glucose decline were comparable in both groups.
• Plasma adrenaline levels significantly increased in healthy controls but not in adrenalectomized subjects.
• Plasma noradrenaline increased similarly in both groups.
• Despite the absence of an adrenaline surge in adrenalectomized subjects, glucagon and PP release during hypoglycemia was not significantly different between the groups.

Conclusions:

• The release of glucagon and pancreatic polypeptide (PP) during insulin-induced hypoglycemia in humans is independent of changes in plasma adrenaline concentration.
• Adrenalectomy does not abolish the counter-regulatory release of glucagon and PP in response to hypoglycemia.